Literature DB >> 7310505

Pathology of arteriovenous malformations embolized with isobutyl-2-cyanoacrylate (bucrylate). Report of two cases.

H V Vinters, G Debrun, J C Kaufmann, C G Drake.   

Abstract

There is controversy as to the possible toxic effects of isobutyl-2-cyanoacrylate (bucrylate) when this substance is used for purposes of therapeutic embolization. Two cases are presented in which cerebral arteriovenous malformations were resected, one 42 days and the other a year after bucrylate embolization. In both, pathological examination revealed a brisk intimal foreign-body giant-cell reaction wherever bucrylate was present in a vessel, along with chronic inflammation in the vessel walls and adjacent brain parenchyma. The findings are discussed in the light of other observations on the histotoxicity of bucrylate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310505     DOI: 10.3171/jns.1981.55.5.0819

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations.

Authors:  Anton Valavanis; Urs Schwarz; Christian R Baumann; Michael Weller; Michael Linnebank
Journal:  J Neurol       Date:  2014-02-08       Impact factor: 4.849

2.  Homologous controlled-viscosity fibrin for endovascular embolization. Part II: catheterization technique, animal experiments.

Authors:  B Richling
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

Review 3.  The histotoxicity of cyanoacrylates. A selective review.

Authors:  H V Vinters; K A Galil; M J Lundie; J C Kaufmann
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

4.  The pathology of encephalic arteriovenous malformations treated by prior embolotherapy.

Authors:  T H Lanman; N A Martin; H V Vinters
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

5.  Neurovascular lesions and endovascular therapy: the role of MR.

Authors:  B A Jabour; J E Dion; R Lufkin; F Viñuela; T Lin; B Moffit; G R Duckwiler; J Bentson
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.